Allan Kirk PhD - 02 Oct 2023 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Director
Signature
/s/ Paul Little, as attorney-in-fact for Allan Kirk, M.D., PhD
Issuer symbol
ELDN
Transactions as of
02 Oct 2023
Net transactions value
+$233,177
Form type
4
Filing time
03 Oct 2023, 16:17:59 UTC
Next filing
13 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELDN Stock Option (Right to Buy) Award $233,177 +150,437 $1.55 150,437 02 Oct 2023 Common Stock 150,437 $1.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase up to 150,437 shares of Common Stock, which option vests with respect to 75,219 shares on October 2, 2024 and with respect to 75,218 shares on October 2, 2025.